शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
FERMENTABSEFermenta Biotech Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 26 May, 2026 · 14:28 IST

Audited Financial Statements (Standalone and Consolidated) for quarter & year ended March 31, 2026 along with auditors report thereon, along with information for AGM and Dividend

FERMENTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.5%Reaction day
₹307.00
prior close
₹302.95
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-6.3% vs market
Pharmaceuticals peers, median of 165sector+0.2%-5.7% vs sector

On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 5.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.7
10m
-3.1
15m
-3.4
30m
-3.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.5+0.7-6.3+0.2-5.7
Next day
-3.6+0.7-4.3-0.1-3.5
2d
-3.8+0.0-3.8-0.3-3.5
3d
-2.0-1.1-0.9-1.3-0.6
4d
+3.2+0.0+3.1-1.3+4.5
5d
+2.6+0.3+2.4-1.7+4.3
1w
+10.4+1.1+9.3-0.6+10.9
15d
+4.0+4.9-0.9-0.5+4.5
1m
+15.6+5.3+10.3+2.6+13.0
2m
+43.2+6.9+36.3+4.0+39.2
3m
+52.9+11.9+41.0+7.1+45.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fermenta Biotech reported standalone total income of Rs. 4,422.09 lakh for FY2026, marginally lower than Rs. 4,502.53 lakh in FY2025, while consolidated total income rose to Rs. 5,478.15 lakh from Rs. 5,254.29 lakh. Standalone profit after tax increased 5.2% to Rs. 676.15 lakh, and consolidated PAT grew 8.7% to Rs. 764.03 lakh. Basic EPS stood at Rs. 23.18 on standalone basis. The board recommended a final dividend of Rs. 3.75 per share (75% on Rs. 5 face value). Statutory auditors SRBC & Co. LLP issued unmodified opinions on both standalone and consolidated financial statements. Exceptional items included Rs. 210.52 lakh for provident fund obligations and Rs. 907.14 lakh recovery of previously written-off receivables. The 74th AGM is scheduled for August 11, 2026.

Likely market impact

The company delivered modest PAT growth on both standalone and consolidated bases despite flat-to-negative revenue, indicating improved operational efficiency. The 75% dividend payout signals confidence in financial stability and rewards shareholders. Clean audit opinions support financial transparency.